Cited by 36

The DOI matches its Crossref record; 6 of the 6 references it cites were found in a registry or an index.

Bace1-dependent amyloid processing regulates hypothalamic leptin sensitivity in obese mice

Meakin, Paul J., Jalicy, Susan M., Montagut, Gemma, Allsop, David J. P., Cavellini, Daniella L., Irvine, Stuart W., McGinley, Christopher, Liddell, Mary K., McNeilly, Alison D., Parmionova, Karolina, Liu, Yu-Ru, Bailey, Charlotte L. S., Dale, J. Kim, Heisler, Lora K., McCrimmon, Rory J., Ashford, Michael L. J.·2018·Scientific Reports

Abstract

Obesity places an enormous medical and economic burden on society. The principal driver appears to be central leptin resistance with hyperleptinemia. Accordingly, a compound that reverses or prevents leptin resistance should promote weight normalisation and improve glucose homeostasis. The protease Bace1 drives beta amyloid (Aβ) production with obesity elevating hypothalamic Bace1 activity and Aβ 1–42 production. Pharmacological inhibition of Bace1 reduces body weight, improves glucose homeostasis and lowers plasma leptin in diet-induced obese (DIO) mice. These actions are not apparent in ob/ob or db/db mice, indicating the requirement for functional leptin signalling. Decreasing Bace1 activity normalises hypothalamic inflammation, lowers PTP1B and SOCS3 and restores hypothalamic leptin sensitivity and pSTAT3 response in obese mice, but does not affect leptin sensitivity in lean mice. Raising central Aβ 1–42 levels in the early stage of DIO increases hypothalamic basal pSTAT3 and reduces the amplitude of the leptin pSTAT3 signal without increased inflammation. Thus, elevated Aβ 1–42 promotes hypothalamic leptin resistance, which is associated with diminished whole-body sensitivity to exogenous leptin and exacerbated body weight gain in high fat fed mice. These results indicate that Bace1 inhibitors, currently in clinical trials for Alzheimer’s disease, may be useful agents for the treatment of obesity and associated diabetes.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1038/s41598-017-18388-6

Cites

6 of 6 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • BACE1 has been implicated in a range of metabolic functions.

    “and BACE1 has been implicated in a range of metabolic functions.”

    From BACE1: More than just a β‐secretase (2022) · cites this paper as [19]

  • The influence of BACE1 on insulin signaling is in part through negative regulators PTEN and PTP1B, which are found to decrease in response to BACE1 inhibition.

    “The influence of BACE1 on insulin signaling is in part through negative regulators PTEN and PTP1B, which are found to decrease in response to BACE1 inhibition.”

    From BACE1: More than just a β‐secretase (2022) · cites this paper as [19]

  • In addition to insulin signaling, other metabolic changes associated with BACE1 have been observed, including lowered plasma leptin and restored hypothalamic leptin sensitivity in obese mice.

    “In addition to insulin signaling, other metabolic changes associated with BACE1 have been observed, including lowered plasma leptin and restored hypothalamic leptin sensitivity in obese mice.”

    From BACE1: More than just a β‐secretase (2022) · cites this paper as [19]

  • Inhibition of BACE1 in DIO mice normalized the STAT3 response, alongside improving glucose homeostasis, reducing hypothalamic inflammation, and normalizing hypothalamic leptin sensitivity via NPY, AgRP, and POMC signaling.

    “Inhibition of BACE1 in diet‐induced obese (DIO) mice normalized the STAT3 response, alongside improving glucose homeostasis, reducing hypothalamic inflammation, and normalizing hypothalamic leptin sensitivity via NPY, AgRP, and POMC signaling.”

    From BACE1: More than just a β‐secretase (2022) · cites this paper as [19]

  • Body weight changes in BACE1 knockout and inhibitor-treated mice are likely through increased energy expenditure.

    “suggesting body weight changes are likely through increased energy expenditure.”

    From BACE1: More than just a β‐secretase (2022) · cites this paper as [19]

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Flagged first, then by citations

Research works printed but not linked: 33

  1. Stockley, J. H. & O’Neill, C. Understanding BACE1: essential protease for amyloid-β production in Alzheimer’s disease. Cell. Mol. Life Sci. 65, 325–3289 (2008). · DOI
  2. Pastorino, L. & Lu, K. P. Pathogenic mechanisms in Alzheimer’s disease. Eur. J. Pharmacol. 545, 29–38 (2006). · DOI
  3. Zhao, J. et al. Beta-site amyloid precursor protein cleaving enzyme 1 levels become elevated in neurons around amyloid plaques: implications for Alzheimer’s disease pathogenesis. J. Neurosci. 27, 3639–3649 (2007). · DOI · Paper page
  4. Zhao, W. Q. & Townsend, M. Insulin resistance and amyloidogenesis as common molecular foundation for type 2 diabetes and Alzheimer’s disease. Biochim. Biophys. Acta. 1792, 482–496 (2009). · DOI · Paper page
  5. Meakin, P. J. et al. Reduction in BACE1 decreases body weight, protects against diet-induced obesity and enhances insulin sensitivity in mice. Biochem. J. 441, 285–296 (2012). · DOI · Paper page
  6. Plucinska, K. et al. Neuronal human BACE1 knockin induces systemic diabetes in mice. Diabetologia 59, 1513–1523 (2016). · DOI · Paper page
  7. Cowley, M. A. et al. Leptin activates anorexigenic POMC neurons through a neural network in the arcuate nucleus. Nature 411, 480–484 (2001). · DOI · Paper page
  8. Pinto, S. et al. Rapid rewiring of arcuate nucleus feeding circuits by leptin. Science 304, 110–115 (2004). · DOI · Paper page
  9. Frederich, R. C. et al. Leptin levels reflect body lipid content in mice: evidence for diet-induced resistance to leptin action. Nat. Med. 1, 1311–1314 (1995). · DOI · Paper page
  10. Enriori, P. J. et al. Diet-induced obesity causes severe but reversible leptin resistance in arcuate melanocortin neurons. Cell Metab. 5, 181–194 (2007). · DOI · Paper page
  11. Simonds, S. E. et al. Leptin mediates the increase in blood pressure associated with obesity. Cell 159, 1404–1416 (2014). · DOI
  12. De Souza, C. T. et al. Consumption of a fat-rich diet activates a proinflammatory response and induces insulin resistance in the hypothalamus. Endocrinology 146, 4192–4199 (2005). · DOI · Paper page
  13. Zhang, X. et al. Hypothalamic IKKbeta/NF-kappaB and ER stress link overnutrition to energy imbalance and obesity. Cell 135, 61–73 (2008). · DOI · Paper page
  14. Thaler, J. P. et al. Obesity is associated with hypothalamic injury in rodents and humans. J. Clin. Invest. 122, 153–162 (2012). · DOI · Paper page
  15. Hosoi, T. et al. Endoplasmic reticulum stress induces leptin resistance. Mol. Pharmacol. 74, 1610–1619 (2008). · DOI
  16. Ozcan, L. et al. Endoplasmic reticulum stress plays a central role in development of leptin resistance. Cell Metab. 9, 35–51 (2009). · DOI · Paper page
  17. Myers, M. G. Jr, Leibel, R. L., Seeley, R. J. & Schwartz, M. W. Obesity and leptin resistance: distinguishing cause from effect. Trends Endocrinol. Metab. 21, 643–651 (2010). · DOI
  18. Zhou, Y. & Rui, L. Leptin signalling and leptin resistance. Front. Med. 7, 207–222 (2013). · DOI · Paper page
  19. Harrison, S. M. et al. BACE1 (beta-secretase) transgenic and knockout mice: identification of neurochemical deficits and behavioural changes. Mol. Cell. Neurosci. 24, 646–655 (2003). · DOI · Paper page
  20. Thaler, J. P., Guyenet, S. J., Dorfman, M. D., Wisse, B. E. & Schwartz, M. W. Hypothalamic inflammation: marker of mechanism of obesity pathogenesis? Diabetes 62, 2629–2634 (2013). · DOI
  21. Cai, D. & Liu, T. Inflammatory cause of metabolic syndrome via brain stress and NF-κB. Aging 4, 98–115 (2012). · DOI
  22. Eketjäll, S. et al. AZ-4217: a high potency BACE inhibitor displaying acute central efficacy in different in vivo models and reduced amyloid deposition in Tg2576 mice. J. Neurosci. 33, 10075–10084 (2013). · DOI
  23. Fonseca, A. C., Ferreiro, E., Oliviera, C. R., Cardoso, S. M. & Pereira, C. F. Activation of the endoplasmic reticulum stress response by the amyloid-beta 1-40 peptide in brain endothelial cells. Biochem. Biophys. Acta 1832, 2191–2203 (2013).
  24. Clarke, J. R. et al. Alzheimer-associated Aβ oligomers impact the central nervous system to induce peripheral metabolic deregulation. EMBO Mol. Med. 7, 190–210 (2015). · DOI · Paper page
  25. Zhang, Y. et al. Amyloid-β induces hepatic insulin resistance by activating JAK2/STAT3/SOCS-1 signaling pathway. Diabetes 61, 1434–1443 (2012). · DOI · Paper page
  26. Vong, L. et al. Leptin action on GABAergic neurons prevents obesity and reduces inhibitory tone to POMC neurons. Neuron 71, 411–420 (2011). · DOI
  27. Briggs, D. I., Lemus, M. B., Kua, E. & Andrews, Z. B. Diet-induced obesity attenuates fasting-induced hyperphagia. J. Neuroendocrinol. 23, 620–626 (2011). · DOI
  28. Rezai-Zadeh, K. et al. Leptin receptor neurons in the dorsomedial hypothalamus are key regulators of energy expenditure and body weight, but not food intake. Mol. Metab. 3, 681–693 (2014). · DOI
  29. Hamilton, D. L. et al. Altered amyloid precursor protein processing regulates glucose uptake and oxidation in cultured rodent myotubes. Diabetologia 57, 1684–1692 (2014). · DOI · Paper page
  30. Bjorbak, C. et al. SOCS3 mediates feedback inhibition of the leptin receptor via Tyr985. J. Biol. Chem. 275, 40649–40657 (2000). · DOI · Paper page
  31. Wilsey, J. & Scarpace, P. J. Caloric restriction reverses the deficits in leptin receptor protein and leptin signalling capacity associated with diet-induced obesity: role of leptin in the regulation of hypothalamic long-form leptin receptor expression. J Endocrinol. 181, 297–306 (2004). · DOI
  32. Martin, T. L. et al. Diet-induced obesity alters AMP kinase activity in hypothalamus and skeletal muscle. J. Biol. Chem. 281, 18933–18941 (2006). · DOI
  33. Ottaway, N. et al. Diet-induced obese mice retain endogenous leptin action. Cell Metab. 21, 877–882 (2015). · DOI

Cited by

Sorted by citations

Metadata

Authors
Meakin, P. J., Jalicy, S. M., Montagut, G., Allsop, D. J. P., Cavellini, D. L., Irvine, S. W., McGinley, C., Liddell, M. K., McNeilly, A. D., Parmionova, K., Liu, Y.-R., Bailey, C. L. S., Dale, J. K., Heisler, L. K., McCrimmon, R. J., & Ashford, M. L. J.
Venue
Scientific Reports
Published
2018-01-08
Volume
8
Issue
1
ISSN
2045-2322
Cited by
36
References
6
Language
en

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review